61.29 F
New York
October 18, 2021

PHAG08

Mexico cheers imminent U.S. border opening, frets over WHO vaccine rules

Reuters
U.S. Border Patrol officers walk along the perimeter fence near the International Bridge between Mexico and the U.S., where migrants seeking asylum in the U.S. are waiting to be processed, in Del Rio, Texas, U.S., September 20, 2021. REUTERS/Marco Bello MEXICO CITY, Oct 13 (Reuters) – Mexico’s president on Wednesday......

WHO says it may be ‘last chance’ to find COVID origins

Reuters
WHO pins hopes on its new scientific advisory panel Calls for China to cooperate, provide early data from Wuhan “It may be our last chance to understand the origins” – Ryan GENEVA, Oct 13 (Reuters) – The World Health Organization said on Wednesday its newly formed advisory group on dangerous......

U.S. administers nearly 402 mln COVID-19 vaccine doses, CDC says

Reuters
A patient receives their coronavirus disease (COVID-19) vaccine booster during a Pfizer-BioNTech vaccination clinic in Southfield, Michigan, U.S., September 29, 2021. REUTERS/Emily Elconin Oct 9 (Reuters) – The United States has administered 401,819,240 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 487,277,035 doses, the U.S.......

Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19

Reuters
An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS BENGALURU, Oct 8 (Reuters) – Two......

Pfizer, BioNTech seek U.S. COVID-19 vaccine clearance for children 5-11

Reuters
WASHINGTON, Oct 7 (Reuters) – Pfizer Inc (PFE.N) and BioNTech SE have asked U.S. regulators to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11, a group for whom no shot is currently allowed, Pfizer said on Thursday. The U.S. Food and Drug Administration has set......

Pfizer, BioNTech seek U.S. COVID-19 vaccine clearance for children 5-11

Reuters
WASHINGTON, Oct 7 (Reuters) – Pfizer Inc (PFE.N) and BioNTech SE have asked U.S. regulators to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11, a group for whom no shot is currently allowed, Pfizer said on Thursday. The U.S. Food and Drug Administration has set......

WHO backs malaria vaccine rollout for Africa’s children in major breakthrough

Reuters
WHO recommendation comes after pilot in 3 African countries Malaria killed 274,000 African kids under 5 in 2019 Nearly half world’s population at risk of disease NAIROBI, Oct 6 (Reuters) – The World Health Organization (WHO) said on Wednesday the only approved vaccine against malaria should be widely given to......

Canada imposes COVID-19 vaccine mandate on federal workers, transportation

Reuters
OTTAWA, Oct 6 (Reuters) – Canada will place unvaccinated federal employees on unpaid leave and require COVID-19 shots for air, train and ship passengers, Prime Minister Justin Trudeau said on Wednesday, as he unveiled one of the world’s strictest vaccine mandate policies. Federal employees will be required to declare their......

Pfizer study to vaccinate whole Brazilian town against COVID-19

Reuters
A vial and sryinge are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration BRASILIA, Oct 6 (Reuters) – Pfizer Inc (PFE.N) will study the effectiveness of its vaccine against COVID-19 by inoculating the entire population over the age of 12 in......

Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups

Reuters
STOCKHOLM, Oct 6 (Reuters) – Sweden and Denmark said on Wednesday they are pausing the use of Moderna’s (MRNA.O) COVID-19 vaccine for younger age groups after reports of possible rare side effects. The Swedish health agency said it would pause using the shot for people born in 1991 and later......

AstraZeneca seeks U.S. authorisation of drug to prevent COVID-19

Reuters
Oct 5 (Reuters) – AstraZeneca (AZN.L) has requested emergency use authorisation from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system. In a statement on Tuesday, the Anglo-Swedish drugmaker said it included data in its filing with......

U.S. Supreme Court rejects challenge to New York tax on opioid companies

Reuters
Tablets of the opioid-based Hydrocodone at a pharmacy in Portsmouth, Ohio, June 21, 2017. REUTERS/Bryan Woolston WASHINGTON, Oct 4 (Reuters) – The U.S. Supreme Court on Monday cleared the way for New York to collect a $200 million surcharge imposed on opioid manufacturers and distributors to defray the state’s costs......

Israel requires COVID-19 booster shots for stricter “green pass”

Reuters
Israeli Izhak Mesfin, 44 years old, receives a third shot of coronavirus disease (COVID-19) vaccine as country launches booster shots for over 30-year-olds, in Rishon Lezion, Israel August 24, 2021. REUTERS/ Nir Elias JERUSALEM, Oct 3 (Reuters) – Israel on Sunday piled pressure on its vaccinated citizens to get a......

Merck pill seen as ‘a huge advance’, raises hope of preventing COVID-19 deaths

Reuters
An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021. Merck & Co Inc/Handout via REUTERS Co will seek U.S. approval for......

Merck KGaA, GSK end partnership on former cancer drug hopeful

Reuters
FRANKFURT, Sept 30 (Reuters) – Germany’s Merck KGaA (MRCG.DE) and Britain’s GlaxoSmithKline (GSK.L) on Thursday ended their collaboration on cancer treatment bintrafusp alfa, once seen as one of Merck’s most promising experimental drugs. Merck said the move was a mutual decision, mostly due to disappointing lung cancer trial data, adding......

Merck to buy Acceleron for about $11.5 bln in rare disease drug push

Reuters
Sept 30 (Reuters) – Merck & Co (MRK.N) is buying Acceleron Pharma Inc (XLRN.O) for about $11.5 billion, broadening its portfolio beyond aging cancer drug Keytruda with potential treatments that could bring in fresh revenue. The deal gives Merck access to Acceleron’s rare disease drug candidate, sotatercept, which the company......

S&P 500, Dow gain amid inflation concerns, debt ceiling debate

Reuters
Dow top gainer, boosted by Boeing Fed Chair Powell expresses frustration over supply chain woes Indexes: Dow up 0.26%, S&P rises 0.16%, Nasdaq off 0.24% NEW YORK, Sept 29 (Reuters) – Wall Street ended firmer on Wednesday in a partial rebound from the previous day’s broad sell-off, with remarks from......

Drug distributors strike 1st opioid settlement with Native American tribe for $75 mln

Reuters
Sept 28 (Reuters) – The three largest U.S. drug distributors will pay more than $75 million to resolve claims they fueled an opioid epidemic in the Cherokee Nation’s territory in Oklahoma, marking the first settlement with a tribal government in the litigation over the U.S. addiction crisis. Cherokee Nation Principal......

COVID-19 pill developers aim to top Merck, Pfizer efforts

Reuters
Sept 28 (Reuters) – As Merck & Co (MRK.N) and Pfizer Inc (PFE.N) prepare to report clinical trial results for experimental COVID-19 antiviral pills, rivals are lining up with what they hope will prove to be more potent and convenient oral treatments of their own. Enanta Pharmaceuticals (ENTA.O), Pardes Biosciences,......

Sanofi ditches mRNA COVID-19 vaccine after rivals’ success

Reuters
To focus on more conventional COVID-19 vaccine with GSK To pursue mRNA technology in influenza, other vaccines Started testing mRNA flu shot in humans in June PARIS, Sept 28 (Reuters) – Sanofi (SASY.PA) is dropping plans for its own mRNA-based COVID-19 vaccine because of the dominance achieved by BioNTech-Pfizer and......

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More